SARS-CoV-2-specific mucosal immunity is possible after intranasal vaccination, and results in a reduction in virus detection in nasal swabs in hamsters and macaques.
British-Swedish biopharmaceutical firm AstraZeneca has in partnership with the University of Oxford rolled out human trials for booster shots against Beta Covid variant.
A single dose of either the Pfizer or AstraZeneca Covid-19 vaccine offers around 60 per cent protection against infection from SARS-CoV-2, the virus causing Covid-19, in adults aged 65 years and above, according to a new study published in The Lancet Infectious.
AstraZeneca said new data from Public Health England (PHE) demonstrated COVID-19 Vaccine AstraZeneca offers high levels of protection against the Delta variant (B.1.617.2; formerly the ‘Indian variant).
Eleven individuals who received the AstraZeneca-Oxford Covid-19 vaccine have developed a rare neurological disorder called Guillain-Barre syndrome, clinicians in India and England have reported in two separate studies.
Brussels: Several European countries have announced they would restart vaccinations with the AstraZeneca Covid-19 jab after the European Medicines Agency (EMA) deemed it “safe and effective”. The EMA statement came after an extensive review of possible blood clot risks, the agency’s chief said on Thursday, following reports that some people had developed blood clots in […]